Clinical utility of circulating tumor DNA (ctDNA) next generation sequencing (NGS) to inform treatment decisions for patients (pts) with advanced solid tumors

被引：0
|
作者：
Gomez Puerto, D. A. [1 ]
Rossi, A. [2 ]
Hernando Calvo, A. [1 ]
Ucha Hermida, J. M. [1 ]
Gomez, M. [3 ]
Matito, J. [3 ]
Vila-Casadesus, M. [3 ]
Morchon Araujo, D. [4 ]
Dienstmann, R. [5 ]
Galceran, J. C. [1 ]
Illescas, D. G. [1 ]
Macarulla Mercade, T. [1 ]
Garralda, E. [1 ]
Saura Manich, C. [1 ]
Elez Fernandez, M. E. [1 ]
Felip, E. [1 ]
Tabernero, J. [1 ]
Vivancos, A. [3 ]
机构：
[1] Vall dHebron Inst Oncol, Med Oncol Dept, Barcelona, Spain
[2] Azienda Osped Univ Integrata Verona, Med Oncol Dept, Verona, Italy
[3] VHIO Valle Hebron Inst Oncol, Genom Dept, Barcelona, Spain
[4] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[5] Vall dHebron Inst Oncol, Oncol Data Sci Dept, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.08.135
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
127P
引用
收藏
页码：S265 / S266
页数：2
相关论文
共 50 条
  • [41] The Clinical Utility of a Next-Generation Sequencing-Based Approach to Detecting Circulating HPV DNA in Patients with Advanced Anal Cancer
    Bhamidipati, Deepak
    Johnson, Jay R.
    Lin, Kangyu
    Pelicano, Helene
    Eng, Cathy
    Huey, Ryan
    Wolff, Robert A.
    Halperin, Daniel M.
    Frumovitz, Michael F.
    Wistuba, Ignacio I.
    Duose, Dzifa Y.
    Mallampati, Saradhi
    Luthra, Rajyalakshmi
    Morris, Van K.
    CANCERS, 2025, 17 (02)
  • [42] Analytical and clinical validation of a next-generation sequencing-based circulating tumor DNA (ctDNA) assay assures its clinical application
    Liu, W.
    Mu, S.
    Yao, J.
    Chen, H.
    Hu, Z.
    Hu, J.
    Chirn, G.
    Kang, H.
    Wang, K.
    Yao, M.
    ANNALS OF ONCOLOGY, 2017, 28
  • [43] Targeted next-generation sequencing (NGS) of circulating tumor cells (CTCs) and matched primary tumors.
    Liu, Stephen V.
    Dempsey, Paul W.
    Strauss, William
    Xu, Yucheng
    Xu, Tong
    Winer-Jones, Jessamine
    Triche, Tim J.
    Quinn, David I.
    McMurdie, Janine
    Defusco, Andre
    Goldkorn, Amir
    CANCER RESEARCH, 2013, 73 (08)
  • [44] Liquid biopsy in the clinic prospective study of plasma circulating tumor DNA (ctDNA) next generation sequencing (NGS) in patients with advanced non-small cell lung cancers to match targeted therapy.
    Sabari, Joshua K.
    Ni, Ai
    Lee, Adrian
    Pavlakis, Nick
    Clarke, Stephen John
    Tandon, Nidhi
    Datta, Sutirtha
    DuBoff, Mariel A.
    Martinez, Andres
    Offin, Michael D.
    Isbell, James M.
    Rusch, Valerie W.
    Jones, David Randolph
    Henderson, Samantha
    Lim, Lee
    Raymond, Chris
    Li, Mark
    Riely, Gregory J.
    Rudin, Charles M.
    Li, Bob T.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [45] Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience
    Caputo, Vincenza
    De Falco, Vincenzo
    Ventriglia, Anna
    Famiglietti, Vincenzo
    Martinelli, Erika
    Morgillo, Floriana
    Martini, Giulia
    Della Corte, Carminia Maria
    Ciardiello, Davide
    Poliero, Luca
    De Vita, Ferdinando
    Orditura, Michele
    Fasano, Morena
    Franco, Renato
    Caraglia, Michele
    Avitabile, Arianna
    Scalamogna, Roberto
    Marchi, Beatrice
    Ciardiello, Fortunato
    Troiani, Teresa
    Napolitano, Stefania
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [46] Correlation of somatic genomic alterations between tissue genomics and circulating tumor DNA (ctDNA) employing next generation sequencing (NGS) analysis in lung and gastrointestinal cancers
    Toor, M. M.
    Bahaj, W.
    Ahmed, Z.
    Kujtan, L.
    Pluard, T. J.
    McNally, M. E.
    Cummings, L. S.
    Island, E.
    Forster, J.
    Kennedy, K. F.
    Subramanian, J.
    Masood, A.
    ANNALS OF ONCOLOGY, 2017, 28
  • [47] Correlation of measurements of tumor heterogeneity based on next-generation sequencing (NGS) of circulating tumor DNA (ctDNA) with clinical outcomes in STEAM, a prospective, randomized, multicenter study in metastatic colorectal cancer (mCRC).
    Yaung, Stephanie
    Tikoo, Nalin
    Nicholas, Alan
    Sommer, Nicolas
    Bendell, Johanna C.
    Hurwitz, Herbert
    Price, Richard
    Palma, John F.
    Lee, John J.
    Casey, Fergal
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [48] DETECTION SYSTEM OF CIRCULATING TUMOR DNA FOR PANCREATIC CANCER USING NEXT-GENERATION SEQUENCING AND ITS CLINICAL UTILITY
    Ohkawa, Kazuyoshi
    Takada, Ryoji
    Ikezawa, Kenji
    Fukutake, Nobuyasu
    Yutaro, Abe
    Toshihiro, Imai
    Kiyota, Ryosuke
    Takatoshi, Nawa
    Ashida, Reiko
    Kukita, Yoji
    Kato, Kikuya
    Katayama, Kazuhiro
    GASTROENTEROLOGY, 2019, 156 (06) : S760 - S760
  • [49] Calculation of Mutational Burden in a Clinical Targeted Next-Generation Sequencing (NGS) Panel for Solid Tumors
    Velu, P.
    Bigdeli, A.
    Hess, P. R.
    Roth, J. J.
    Rosenbaum, J. N.
    Morrissette, J. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2017, 19 (06): : 1024 - 1025
  • [50] Mobocertinib efficacy in patients with NSCLC and EGFR exon 20 insertion mutations (ex20ins) identified by next-generation sequencing (NGS) of circulating tumor DNA (ctDNA)
    Neal, Joel W.
    Li, Ying
    Yu, Ziji
    Fram, Robert J.
    Danes, Christopher
    Vincent, Sylvie
    Piotrowska, Zofia
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345